Bring your own G protein

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1079-1082

  Hildebrandt, John D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HYBRID PROTEIN; THROMBOXANE A2;

CARBOXY TERMINAL SEQUENCE; DIMERIZATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVIEW;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SIGNAL TRANSDUCTION;

EID: 33645109077     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.022921     Document Type: Review

References (49)

1. Barclay E, O'Reilly M, and Milligan G (2005) Activation of an alpha-2A adrenoceptor-G alpha-o1 fusion protein dynamically regulates the palmitoylation status of the G protein but not the receptor. Biochem J 385:197-206.
2. sα fusion protein. Proc Natl Acad Sci USA 91:8827-8831.
3. Bulenger S, Marullo S, and Bouvier M (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26:131-137.
4. i proteins. J Biol Chem 273:10367-10375.
5. Carrillo JJ, Pediani J, and Milligan G (2003) Dimers of class A G protein coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 278:42578-42587.
6. Colquhoun D (1998) Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125:923-947.
7. αo protein. Neuropharmacology 38:1035-1041.
8. Fong CW and Milligan G (1999) Analysis of agonist funciton at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G proteins. Biochem J 342:457-463.
9. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, and Bollag G (1998) Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by G alpha-13. Science (Wash DC) 280:2112-2114.
10. Hoare SRJ (2000) G protein coupled receptors: what limits high-affinity agonist binding? Trends Pharmacol Sci 21:82-83.
11. Hosoi T, Koguchi Y, Sugikawa E, Chikada A, Ogawa K, Tsuda N, Suto N, Tsunoda S, Taniguchi T, and Ohnuki T (2002) Identification of a novel human eicosanoid receptor. J Biol Chem 277:31459-31465.
12. Javitch JA (2004) The ants go marching two by two: oligomeric structure of G protein coupled receptors. Mol Pharmacol 66:1077-1082.
13. i1α. Mol Pharmacol 56:684-692.
14. Kenakin T (2003) Ligand-selective receptor comformations revisited: the promise and the problem. Trends Pharmacol Sci 24:346-354.
15. Kozasa T and Gilman AG (1995) Purification of recombinant G proteins from Sf9 cells by hexahistidine tagging of associated subunits. J Biol Chem 270:1734-1741.
16. Kreutz B, Yau DM, Nance MR, Tanabe S, Tesmer JJG, and Kozasa T (2006) A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha 12/13 proteins. Biochemistry 45:167-174.
17. Leff P, Scaramellini C, Law C, and McKechnie K (1997) A three-state receptor model of agonist action. Trends Pharmacol Sci 18:355-362.
18. 11 requires both βγ interactions and an aromatic group four amino acids from the C terminus of the G protein. J Biol Chem 277:25707-25714.
19. s. J Biol Chem 274:31014-31019.
20. Massotte D, Brillet K, Kieffer BL, and Milligan G (2002) Agonists activate Gil alpha or Gi2 alpha fused to the human mu opioid receptor differently. J Neurochem 81:1372-1382.
21. 1 adrenoceptor. Mol Pharmacol 62:747-755.
22. Milligan G (2000) Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol Sci 21:24-28.
23. Milligan G (2002) The use of receptor G protein fusion proteins for he study of ligand activity. Recept Channels 8:309-317.
24. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.
25. Milligan G, Feng G-J, Ward RJ, Sartania N, Ramsay D, McLean AJ, and Carrillo JJ (2004) G protein-coupled receptor fusion proteins in drug discovery. Curr Pharm Des 10:1989-2001.
26. Molinari P, Ambrosio C, Riitano D, Sbraccia M, Gro MC, and Costa T (2003) Promiscuous coupling at receptor-Gα fusion proteins. J Biol Chem 278:15778-15788.
27. Montuschi P, Barnes PJ, and Roberts LJ (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800.
28. Moon H-E, Bahia DS, Cavalli A, Hoffmann M, and Milligan G (2001) Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of the Gi1 by mutation of a receptor/G protein contact interface. Neuropharmacology 41:321-330.
29. 2+ responses by wild-type, mutant Ser200Ala and Ser204Ala alpha-2A-adrenoceptor: G15 fusion proteins: evidence for multiple ligand-activation binding sites. Br J Pharmacol 130:1505-15112.
30. Perez DM and Karnik SS (2005) Multiple signaling states of G protein-coupled receptors. Pharmacol Rev 57:147-161.
31. Riobo NA and Manning DR (2005) Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol Sci 26:146-154.
32. Seifert R, Wenzel-Seifert K, and Kobilka B (1999) GPCR-G alpha fusion proteins: molecular analysis of receptor-G protein coupling. Trends Pharmacol Sci 20:383-389.
33. Seifert R, Wenzel-Seifert K, and Kobilka BK (2000) Reply to G protein coupled receptors: what limits high-affinity agonist binding? Trends Pharmacol Sci 21:83-84.
34. 13. J Biol Chem 269:19796-19802.
35. 2 adrenergic receptor to engineer a receptor effector complex for gene therapy. J Biol Chem 276:31596-31601.
36. 11α is not required for interaction with βγ complex. J Biol Chem 276:35883-35890.
37. Strathmann M and Simon MI (1991) G alpha-12 and G alpha-13 subunits define a fourth class of G protein alpha subunits. Proc Natl Acad Sci USA 86:7407-7409.
38. Strathmann M, Wilkie TM, and Simon MI (1989) Diversity of the G protein family: Sequences from five additional alpha subunits in the mouse. Proc Natl Acad Sci USA 86:7404-7409.
39. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, and Takuwa Y (2003) Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Ro and Gi pathway integrated downstream of a single G protein -coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23:1534-1545.
40. Takeda S, Yamamoto A, Okada T, Matsumura E, Nose E, Kogure K, Kojima S, and Haga T (2003) Identification of surrogate ligands for orphan G protein-coupled receptors. Life Sci 74:367-377.
41. Terrillon S and Bouvier M (2004) Roles of G-protein-coupled receptor dimerization. From ontogeny to signalling regulation. EMBO (Eur Mol Biol Organ) Rep 5:30-34.
42. Ugur O, Onaran HO, and Jones TLZ (2003) Partial rescue of functional interactions of a nonpalmitoylated mutant of the G protein G alpha-s by fusion to the beta-adrenergic receptor. Biochemistry 42:2607-2615.
43. z fusion protein. J Biol Chem 275:4166-4170.
44. o subunit. J Biol Chem 274:37435-37442.
45. Ward RJ and Milligan G (1999) An Asp79Asn mutation of the alpha-2A adrenoceptor interferes equally with agonist activation of individual Fa alpha-family G protein subtypes. FEBS Lett 462:459-463.
46. Ward RJ and Milligan G (2002) Reciprocal mutations of highly conserved residues in transmembrane helices 2 and 7 of the alpha-2A adrenoceptor restore agonist activation of Gi1 alpha. Cell Signal 14:139-144.
47. i1α by expressing the proteins from chimeric open reading frames. J Biol Chem 272:24673-24678.
48. Wurch T and Pauwels PJ (2001) Analyatical pharmacology of G protein-coupoled receptors by stoichiometric expression of the receptor and G alpha protein subunits. J Pharmacol Toxicol Methods 45:3-16.
49. 2 receptor activity. Mol Pharmacol 69:1433-1440.